IQV · XBRL financial data

Iqvia Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (IQV's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers3,868*3,7373,8143,8963,958*3,8294,0174,1004,364*4,1514,3684,428
Gross profit—827863915————————
Selling, general and administrative556*508509522453*508509514468*502574569
Operating income (loss)501*506520550626*496506553627*514506572
Interest income12*11121311*11101311*10712
Interest expense181*166163170171*165182189193*192197203
Other income (expense)47*(11)67(44)78*(15)(11)3194*(4)(12)5
Income tax expense (benefit)(102)*497565112*61567659*596076
Net income (loss)469*288363285437*249266331514*274256350
Earnings per share, basic USD per share2.57*1.581.991.572.44*1.421.551.943.02*1.631.542.13
Earnings per share, diluted USD per share2.54*1.561.971.552.42*1.401.541.932.99*1.611.532.10
Weighted average shares, basic millions of shares182*182182182179*176172170170*168166165
Weighted average shares, diluted millions of shares184*184184184181*177173172172*170167167

Balance sheet

CSV

Fiscal quarters (IQV's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents1,3761,4441,5451,5721,7021,7402,0391,8141,9801,9471,9092,249
Marketable securities120131133140141136149158161156171173
Total current assets5,5965,6515,6225,6325,8295,9116,3455,9796,2496,2206,2266,451
Property and equipment, net523513503513535533536525533516547534
Right-of-use asset296278265259238235280299290293304313
Goodwill14,56714,51614,47715,09114,71015,02715,61115,94816,61616,54416,60416,900
Total assets26,68126,57426,39827,18026,89927,32228,63228,72729,94429,67529,88130,474
Accrued liabilities2,855———2,948———2,971———
Current portion of long-term debt7187171,1671,2191,1451,2221,3132,1641,8401,8442,2941,244
Total current liabilities6,4916,4486,6206,9926,9577,1797,5728,5088,3388,3298,8157,777
Long-term debt12,95512,81912,09112,29312,83813,10814,17712,79313,88413,98913,70514,823
Lease liability, non-current223204192188173177210233225232242247
Total liabilities20,56920,23019,68420,21320,83221,33722,84622,43923,31423,32623,58023,683
Retained earnings4,6924,9805,3435,6286,0656,3146,5806,9117,4257,6997,9558,305
Total stockholders' equity6,1126,3446,7146,9676,0675,9775,7786,1606,5036,2216,1716,660
Total liabilities and equity26,68126,57426,39827,18026,89927,32228,63228,72729,94429,67529,88130,474
Common shares outstanding (cover page) millions of shares182182182182176≈173≈170170170167165165
  • ≈ Rounded on cover: the filing states this count rounded, and it sits more than 1% off the weighted shares for the period.

Cash flows

CSV

Fiscal quarters (IQV's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)469*288363285437*249266331514*274256350
Stock-based compensation45*5648*54*48*7260*55*60*6595*83*
Depreciation and amortization316*264269278303*265276286317*288292321
Net cash from operating activities747*522588*721*885*568443*908*735*618558*825*
Net cash from investing activities(212)*(314)(221)*(599)*(310)*(305)(346)*(550)*(1,104)*(196)(381)*(559)*
Share repurchases229*00*200*1,150*375657*0*212*552398*0*
Net cash from financing activities(420)*(106)(260)*(137)*(375)*(258)145*(572)*535*(433)(214)*78*
Net change in cash152*68101*27*130*38299*(225)*166*(33)(38)*340*

Compare with peers

SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Iqvia Holdings2,2494,428825*164.8M 10-QSep 30, 2026
Incyte3,2761,557(675)*203.8M 10-QSep 30, 2026
Charles River Laboratories International200983254*47.9M 10-QSep 26, 2026
Medpace Holdings705716217*28.0M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.